Sign in
4

Changes in Ownership

BOSTON SCIENTIFIC CORP Filed Acc 0001225208-23-006012

EVP & Group Pres, Cardiology sold 63,339 shares at $53.60 ($3,394,856)

  • EVP & Group Pres, Cardiology acquired 56,921 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Fitzgerald Joseph Michael · EVP & Group Pres, Cardiology

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-05-16 Exercise or conversion : show line 1 in the form +56,921 $13.08 $744,527 277,198 D
2023-05-16 Sale : show line 2 in the form −63,339 $53.60 $3,394,856 213,859 D
Open-market sales · 63,339 sh · avg $53.60 · $3,394,856

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-05-16 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −56,921 0 D
Loading xslF345X04/doc4.xml…